We are excited to share that our experts will be attending the 11th ITOC Conference – ImmunoTherapy of Cancer Association (ITOC) from April 03 to 04!
As immunotherapy continues to transform cancer treatment, we are committed to supporting researchers with high-quality oncology biomarkers and immune checkpoint inhibitor antibodies. This event will be a great opportunity to connect and exchange ideas on the latest advancements in cancer immunotherapy.
Let’s meet at the iTOC, and let us know how we can support!